Remedy Meds
Featured PartnerFast-growing GLP-1 telehealth platform with flat dose-agnostic pricing, bundled labs, and a pending $500M acquisition of Thirty Madison.
What we like
What to watch
Full Review
Remedy Meds has achieved remarkable traction in under two years, scaling to over 450M in annual revenue and 250,000 members with a compelling value proposition: dose-agnostic pricing that does not increase as patients titrate up. The pending 500M acquisition of Thirty Madison would transform it into a diversified telehealth platform spanning mens health, womens health, migraines, and dermatology via Keeps, Nurx, and Cove. The Trustpilot score (4.6/5, 11,000+ reviews) reflects strong patient satisfaction, and the all-inclusive bundling of labs, unlimited visits, meal plans, and shipping at a flat rate is a genuine differentiator in the GLP-1 space.
Last researched: 2026-03-30
Pricing
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Compounded Semaglutide | Weight Loss / GLP-1 | $299 | ● Consults● Lab work● Shipping | Price-lock guarantee at $199/mo reported No subscription needed |
| Compounded Tirzepatide | Weight Loss / GLP-1 | $399 | ● Consults● Lab work● Shipping | No subscription needed |